NFXL1

NFXL1 is an endoplasmic reticulum-localized E3 ubiquitin ligase that restrains antigen presentation by targeting MHC-I for degradation in pancreatic ductal adenocarcinoma cells (PMID:42214332, PMID:39554122). It physically associates with MHC-I at the ER and ubiquitylates it, channeling MHC-I into the TEX264-NBR1 autophagic complex for capture and subsequent lysosomal degradation; elevated NFXL1 correlates with reduced surface MHC-I, linking its activity to suppression of immune surveillance (PMID:42214332, PMID:39554122). Under basal conditions in non-cancer cell lines NFXL1 shows cytoplasmic rather than nuclear localization (PMID:27053962). Beyond these findings, the regulation and broader substrate range of human NFXL1 have not been characterized in the available corpus.

1. 2010 Low

   Before any functional data, sequence analysis raised the question of what enzymatic activity NFX1-like proteins possess, predicting an E3 ubiquitin ligase role from a conserved RING motif.

   Evidence Manual sequence analysis, hidden Markov models, and phylogenetic analysis identifying a C4HC3 RING finger signature

   PMID:20522174

   Open questions at the time

   • No experimental validation of E3 ligase activity
   • No substrate identified
   • Prediction based on domain inference only
2. 2016 Medium

   To address where NFXL1 acts, subcellular localization was tested, establishing a cytoplasmic distribution under standard conditions rather than constitutive nuclear residence.

   Evidence Immunofluorescence in HEK and SH-SY5Y cells

   PMID:27053962

   Open questions at the time

   • Single method, single lab
   • No functional consequence demonstrated
   • Conditions driving any relocalization not defined
3. 2017 Low

   An upstream regulatory question was partially addressed by showing Tbx6 positively regulates Nfxl1 expression in mice.

   Evidence Gene expression comparison between Tbx6+/- and Tbx6-/- mice

   PMID:28664156

   Open questions at the time

   • Correlative expression change only
   • No direct evidence Tbx6 binds the Nfxl1 locus
   • No protein-level mechanism for NFXL1
4. 2020 Medium

   Loss-of-function work on the wheat ortholog established a negative-regulatory role in pathogen defense, the first phenotypic evidence for an NFXL1-family gene.

   Evidence VIGS and CRISPR/Cas9 knockout of TaNFXL1 with Fusarium graminearum resistance and DON-induction assays

   PMID:31790345

   Open questions at the time

   • Findings in wheat ortholog, not human NFXL1
   • Molecular mechanism of repression unresolved
   • No biochemical link to ubiquitylation
5. 2026 High

   The central mechanistic question — what NFXL1 does at the protein level — was answered by placing it as an ER E3 ligase that ubiquitylates MHC-I and routes it through autophagic-lysosomal degradation, defining its role in immune evasion.

   Evidence Genome-wide CRISPRi screen, ER exit synchronization assays, co-immunoprecipitation of MHC-I with TEX264-NBR1, and functional knockdown with surface/total MHC-I readouts in PDAC cells

   PMID:39554122 PMID:42214332

   Open questions at the time

   • Direct demonstration of NFXL1 catalytic transfer of ubiquitin to MHC-I not isolated from the pathway readout
   • Ubiquitin chain type and acceptor sites on MHC-I undefined
   • Whether the ER E3 role generalizes beyond PDAC unknown

• Whether the predicted RING-dependent catalytic activity directly drives MHC-I ubiquitylation, and what additional substrates NFXL1 acts on, remain open.
• No in vitro reconstitution of NFXL1 E3 activity
• Substrate repertoire beyond MHC-I unknown
• Regulation of NFXL1 in normal physiology uncharacterized